✦ LIBER ✦

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

✍ Scribed by T. Hatschek; L. Carlsson; Z. Einbeigi; E. Lidbrink; B. Linderholm; B. Lindh; N. Loman; M. Malmberg; S. Rotstein; M. Söderberg; M. Sundquist; T. M. Walz; M. Hellström; H. Svensson; G. Åström; Y. Brandberg; J. Carstensen; M. Fernö; J. Bergh

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 329 KB
Volume: 131
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1880-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin and paclitaxel with G-CSF sup

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

✍ R. I. Lalisang; F. L. G. Erdkamp; C. J. Rodenburg; C. T. A. M. Knibbeler-van Ros 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB

Randomized multicenter Phase II trial of

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

✍ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Liposome-encapsulated doxorubicin compar

Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma

✍ Lyndsay Harris; Gerald Batist; Robert Belt; Douglas Rovira; Rudolph Navari; Noza 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

A Phase II trial of the combination of v

A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines

✍ George Orphanos; Athanasios Alexopoulos; Savvoula Malliou; George Ioannidis; Ale 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

A phase I/randomized phase II, non-compa

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB